Anjelli Wignakumar

Anjelli Wignakumar

Auto-generated profile, based on publicly available information

Anjelli Wignakumar

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, Weston, FL, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2023 in Surgery
Verified
Journal Article
Closed access
SESameh Hany Emile
Sameh Hany Emile
NHNir Horesh
Nir Horesh
MFMichael Freund
Michael Freund
Gianluca PellinoGianluca Pellino
Gianluca Pellino
LOLucia Oliveira
Lucia Oliveira
SWSteven D. Wexner
Steven D. Wexner

24 May 2024 in The American Journal of Surgery
Verified
Journal Article
Open access
JDJustin Dourado
Justin Dourado
PRPeter Rogers
Peter Rogers
SESameh Emile
Sameh Emile
AWAnjelli Wignakumar
Anjelli Wignakumar
BWBrett Weiss
Brett Weiss
SWSteven D. Wexner
Steven D. Wexner
Colon cancer pathological and clinical staging may be disoncordant. This study assessed patients with colon cancer in whom the nodal status was clinically understaged. Patients with stage I-III clinical node-negative colon cancer from the National Cancer Database were included. Regression analyses were conducted to elucidate risk factors for clinical nodal understaging and a scoring system was developed to identify high-risk patients. The study included 94,945 patients with 78.4 ​% of patients correctly staged and 21.6 ​% clinically understaged. The predictors of nodal positivity in clinically understaged patients were age <65 (OR 1.43), left-sided tumors (OR 1.41), elevated CEA (OR 2.03), moderately (OR 1.81) or poorly/undifferentiated tumors (OR 3.76), T1 tumors (OR 1.29), signet-ring cell histology (OR 2.26), and microsatellite-stable tumors (OR 1.4). Patients with colon cancer and the above factors are more likely to have their nodal status clinically understaged. A scoring system has been developed to identify high-risk patients.

23 November 2023 in Surgery
Verified
Journal Article
Closed access
SESameh Hany Emile
Sameh Hany Emile
AWAnjelli Wignakumar
Anjelli Wignakumar
NHNir Horesh
Nir Horesh
ZGZoe Garoufalia
Zoe Garoufalia
PRPeter Rogers
Peter Rogers
SWSteven D. Wexner
Steven D. Wexner

28 November 2025 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
SESameh Hany Emile
Sameh Hany Emile
NHNir Horesh
Nir Horesh
AWAnjelli Wignakumar
Anjelli Wignakumar
MBMarylise Boutros
Marylise Boutros
SWSteven D. Wexner
Steven D. Wexner
Stage IV colorectal cancer (CRC) is associated with poor 5-year survival <15 %. We aimed to investigate the association between T and N stages of stage IV CRC and survival. A retrospective population-based cohort analysis of patients who underwent surgery for stage IV colorectal adenocarcinomas from the SEER database (2010-2020) was conducted. T and N stages of the primary CRC were examined as independent predictors for cancer-specific survival (CSS) against other factors in a multivariable Cox regression analysis. the main outcome measure was 5-year CSS. Kaplan-Meier statistics were used to show differences in CSS among the groups. 73,427 patients (52.4 % male; mean age: 64.9 years) were included. 5-year CSS was 20.7 % (95 %CI:20.4-21 %). 5-year CSS rate significantly decreased with increased T stage (T1 and T2 = 33.3 %, T3 = 22.1 %, T4 = 17.4) and with nodal disease (N0 = 31.2 %, N1 = 23.6 %, N2 = 14.5 %). T4 tumors (HR:1.33, 95 %CI:1.05, 1.68; p = 0.017) and N1 and N2 disease (HR:1.27 and 1.59, respectively; p < 0.001) were independently associated with reduced CSS. Other independent predictors were increased age (HR:1.02; p < 0.001), male sex (HR:1.07; p = 0.005), Black race (HR:1.19; p < 0.001), signet-ring cell histology (HR:1.44; p < 0.001), poorly differentiated (HR:1.58; p < 0.001) and undifferentiated (HR:1.76; p < 0.001) carcinomas, perineural invasion (HR:1.23; p < 0.001), tumor deposits (HR:1.03; p < 0.001), elevated CEA levels (HR:1.96; p < 0.001), and multiple organ metastases (HR:1.82; p < 0.001). CSS improved with distant metastases resection (HR:0.86; p < 0.001) and systemic therapy (neoadjuvant: HR = 0.51, adjuvant: HR = 0.48, combined: HR = 0.40; p < 0.001). Advanced T and N stages of stage IV CRC were associated with worse CSS. Older, male, and Black patients with high-grade, mucinous, and signet-ring cell carcinomas, perineural invasion, tumor deposits, and elevated CEA levels had worse CSS. Systemic treatments conferred >50 % increase in CSS in stage IV disease.

15 July 2025 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
SESameh Hany Emile
Sameh Hany Emile
NHNir Horesh
Nir Horesh
ZGZoe Garoufalia
Zoe Garoufalia
AWAnjelli Wignakumar
Anjelli Wignakumar
MPMichal Perets
Michal Perets
SWSteven D. Wexner
Steven D. Wexner

8 March 2026 in Colorectal Disease
Verified
Journal Article
Closed access
AWAnjelli Wignakumar
Anjelli Wignakumar
IGIlana Grosman
Ilana Grosman
RGRachel Gefen
Rachel Gefen
MOMarcus Oosenbrug
Marcus Oosenbrug
SWSteven D. Wexner
Steven D. Wexner